Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...

Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

Once thought to be under control, yellow fever is making an alarming comeback, and the numbers are climbing. With treatment ...

As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency ...

As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix's, an established company ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

mRNA vaccine research will be stripped of $500 million in funding from the U.S. Department of Health and Human Services (HHS). The agency listed 22 projects that will be affected, many of which are ...

Two months after ExCellThera’s Zemcelpro (UM171 cell therapy) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), the European ...